Why are we the Bright Cell Healthcare Institute?
WE WORK EVERY DAY TO DEVELOP NEW AND IMPROVED ADVANCED MEDICAL THERAPY ALTERNATIVES
Our scientific team focuses on improving the safety, efficacy, and ease of use of our products, thereby maximizing their accessibility. We have developed optimal techniques and procedures for the production, storage, and application of human adult stem cells (ASC).
This level of technological development places us at the forefront internationally in this field and gives us clarity regarding the conceptual and technological gaps that need to be filled for the development of new ASC therapy alternatives, achieving consistent therapeutic results without compromising patient safety. And receive first-rate quality health care products from the world’s leading regenerative medicine providers with most patient satisfaction
This level of technological development places us at the forefront internationally in this field and gives us clarity regarding the conceptual and technological gaps that need to be filled for the development of new ASC therapy alternatives, achieving consistent therapeutic results without compromising patient safety. And receive first-rate quality health care products from the world’s leading regenerative medicine providers with most patient satisfaction
As of March 18, 2024, there are now 36 gene therapies approved by the FDA, with an additional 500 in the pipeline and the expectation that 10–20 will be approved annually by 2025, based on information about gene therapy trials on ClinicalTrials.gov
Overview of registered MSC-based clinical trial phase and status.
A. Pie chart distribution of clinical trials according to investigation phases.
B. Bar blot of clinical trials according to the study status. Notably, a large number of clinical trials are lacking updates on the progressing status. All data was obtained by July 14th, 2021
MSC-based clinical trials categorized by indications. Data gathered from ClinicalTrials.gov. GvHD: Graft-versus-host disea
Overview of the number of registered participants for MSC-based clinical trials according to countries. Data was collected by July 14th, 2021
Why work with Bright Cell Healthcare Institute
Facilities
Our facilities comply with the highest quality standards for pharmaceutical production, which allows us to ensure compliance both with Good Manufacturing Practices (GMP) and U.S FDA facility registration.
Professionals
We are healthcare professionals with master’s and doctoral degrees and certified experience in the practice of regenerative medicine. We stay updated on international advances in cellular therapy alternatives. We have a qualified team to provide technical and scientific support in the use of various advanced medical therapy alternatives, especially human adult stem cells (ASC).
Passion
Our passion lies in the development and optimization of effective, safe, and user-friendly cellular therapy alternatives to improve therapeutic outcomes for the benefit of patients and their treating physicians.
Development
We have developed simple and effective protocols for the production, storage, and use of stem cells.
Technology
Our internationally proved technology improves the safety and effectiveness. We can produce a huge number of cells from different tissues in a short time
Samples
We start from a small sample placed in containers supplied by us, that later would be collected according to your instructions.
Safety
We have implemented a practical and reliable system for the application of stem cells, that guarantees their safety and survival for 48 hours at room temperature.
Storage
We have developed a DMSO-free solution to store human stem cells, which allows us to guarantee their easy and prompt availability for their therapeutic use.
Copyright © 2025 Brightcell-Healthcare.com All rights reserved 